Sacituzumab govitecan wasn't cost-effective in HR+/HER2- metastatic breast cancer for third-party payers in the US. A study found unique risk factors for cardiovascular disease and mortality in patients with age-related macular degeneration. Patients with rheumatoid arthritis with lower hemoglobin levels may be more likely to have increased progression over time. John Bencich, CEO of Achieve Life Sciences, discusses the smoking cessation aid, cytisinicline, and its approval in the US. Researchers established tranexamic acid was safe and effective in patients with rheumatoid arthritis following TKA. Researchers compared intravenous thrombolysis with the conventional alteplase against thrombolysis with tenecteplase. In the ZEPHYR 2 trial, researchers assessed benralizumab in patients with variations of severe eosinophilic asthma. The annual meeting of American Society of Hematology Published studies have shown that mental disorders are common risk factors for cardiovascular diseases (CVD); however, ... In an article recently published in BMC Musculoskeletal Disorders, researchers attempted to uncover biomarkers for ... The American College of Cardiology's Annual Scientific Session & Expo Coverage of the 63rd American Society of Hematology Annual Meeting & Exposition (ASH 2021) American Heart Association (AHA) Scientific Sessions 2021 The American College of Cardiology's 70th Annual Scientific Session & Expo Scientific Session & Expo (ACC.21) Transcatheter Cardiovascular Therapeutics (TCT) 2021 Diffuse large B-cell lymphoma (DLBCL) data at the 62nd American Society of Hematology Annual Meeting & Exposition (ASH 2020). CLL, MCL, and WM topics from the 62nd American Society of Hematology Annual Meeting & Exposition (ASH 2020) Myelodysplastic syndrome (MDS) topics from the 62nd American Society of Hematology Annual Meeting & Exposition (ASH 2020) Transcatheter Cardiovascular Therapeutics (TCT) 2020 The American College of Cardiology's 69th Annual Scientific Session & Expo Scientific Session & Expo (ACC.20)